This notion was also suggested by others showing that knocking out RNASEH2A in cervical cancer HeLa cells results in an increased sensitivity to ataxia telengiectasia and Rad3-related (ATR) inhibitors compared to knocking out RNASEH2B [48]. The gene discussed is RNASEH2A; the disease is cervical cancer.